Patient interest fairly high for melanoma genetic risk testing

July 10, 2018

(HealthDay)—There is moderately high interest in genetic testing for melanoma risk among the general population, according to a study published in the June issue of JAMA Dermatology.

Jennifer L. Hay, Ph.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined interest in and uptake of MC1R testing in the general population and assessed patterns across demographic and skin cancer risk factors. Patients were randomized to either usual-care condition (National Cancer Institute skin cancer pamphlet for diverse skin types) or an MC1R test offer (following three web-based educational modules presenting the rationale, benefits, and drawbacks of MC1R testing).

The researchers found that 232 of the 499 participants randomized to MC1R testing logged on to the website, and of these, 88 percent (204 participants) requested testing and 82 percent (167 participants) returned the test kit. Race/ethnicity and education were the strongest predictors of logging on to the website (odds ratio for Hispanics versus non-Hispanic whites, 0.5; odds ratio for more than versus high school or less, 2.7). Sunburn history was the strongest predictor of ordering the test (odds ratio, 5.4, versus no sunburn history).

"There were moderately high levels of MC1R test interest and uptake in this diverse sample," the authors write. "Addressing potential barriers to testing may be warranted as genomic information becomes integrated into approaches to the precision prevention of ."

Explore further: Gender disparity observed in cancer genetic testing in the U.S.

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Gender disparity observed in cancer genetic testing in the U.S.

May 3, 2018
(HealthDay)—Specific demographic groups have lower cancer genetic testing, including unaffected men compared with unaffected women, according to a research letter published online April 26 in JAMA Oncology.

Sun defenses up in transplant patients after skin cancer study

June 13, 2018
(HealthDay)—For organ transplant recipients, participation in a skin cancer research study is associated with increased use of multiple sun protection behaviors, according to a research letter published online June 6 in ...

Disordered eating behaviors up for overweight young adults

July 8, 2018
(HealthDay)—Young adults at a weight status classified as overweight or obese have increased prevalence of disordered eating behaviors (DEBs), according to a study published online June 11 in the Journal of General Internal ...

Is there association between MC1R and melanoma risk after controlling for sun?

April 6, 2016
There is a well-described association between UV radiation exposure from the sun and the development of melanoma. The development of melanoma independent of sun exposure has only recently been described in mice.

Researchers discover why redheads are more prone to melanoma

September 6, 2017
Red-haired people are known for pale skin, freckles, poor tanning ability and unfortunately, an increased risk for developing skin cancer. Research has shown that they have variants in Melanocortin 1 Receptor (MC1R), a protein ...

Hydrochlorothiazide tied to non-melanoma skin cancer risk

March 22, 2018
(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

Recommended for you

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.